Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis

Published:2020-02 Issue: Volume:188 Page:112006
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Runfola Massimiliano,Sestito Simona,Bellusci Lorenza,La Pietra Valeria,D’Amore Vincenzo Maria,Kowalik Marta Anna,Chiellini Grazia,Gul Sheraz^ORCID,Perra Andrea,Columbano Amedeo,Marinelli Luciana,Novellino Ettore,Rapposelli Simona^ORCID

Funder

University of Pisa

AIRC

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference40 articles.

1. Physiological and molecular basis of thyroid hormone action;Yen;Physiol. Rev.,2001

2. Mechanisms of thyroid hormone action;Brent;J. Clin. Investig.,2012

3. Perspectives on thyroid hormone action in adult neurogenesis;Kapoor;J. Neurochem.,2015

4. A selective thyroid hormone beta receptor agonist enhances human and rodent oligodendrocyte differentiation;Baxi;Glia,2014

5. Thyroid hormone mediated modulation of energy expenditure;Vaitkus;Int. J. Mol. Sci.,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and preclinical testing of a selective beta-subtype agonist of thyroid hormone receptor ZTA-261;Communications Medicine;2024-08-06

2. Drug discovery targeting thyroid hormone receptor β (THRβ) for the treatment of liver diseases and other medical indications;Acta Pharmaceutica Sinica B;2024-08

3. Letter: Drug interaction in resmetirom times;Alimentary Pharmacology & Therapeutics;2024-07-16

4. Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs;Drug Discovery Today;2024-06

5. Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges;Pharmaceuticals;2023-08-25